Drug Profile
SCH 48755
Latest Information Update: 26 Jun 2001
Price :
$50
*
At a glance
- Originator Schering-Plough
- Class Antineoplastics; Nucleosides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 26 Jun 2001 No-Development-Reported for Cancer in USA (Unknown route)
- 10 Jul 1997 New profile
- 10 Jul 1997 Preclinical development for Cancer in USA (Unknown route)